A Missouri jury found Abbott Laboratories (ABT) and a unit of Reckitt Benckiser (RBGLY) not responsible for an infant death originally claimed to be tied to the company's baby formulas. The two health companies are seeing their shares rise on Friday following this legal victory.

Market Domination's Julie Hyman and Josh Lipton report more on the story.

To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

This post was written by Luke Carberry Mogan.